Cat. No. 4520
Alternative Name: Cytosine b-D-arabinofuranoside
Chemical Name: 4-Amino-1-β-D-arabinofuranosyl-2(1H)-pyrimidinone
Biological ActivityNucleoside analog of deoxycytidine; inhibits DNA replication by incorporating into DNA (IC50 = 0.04 μM in L1210 and CEM cell lines). Displays no inhibitory effects on RNA synthesis. Causes S phase cell cycle arrest in ML-1 cell lines; cytotoxic in L5817Y leukemia cells. Antineoplastic and antileukemic agent.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Certificate of Analysis / Safety Data Sheet
Yang et al (1986) Effect of cytarabine upon metabolism of phospholipids in leukemia L5178Y cells. Acta Pharmacol. Sin. 7 368. PMID: 2954403.
Breistøl et al (1999) Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models. Cancer Res. 59 2944. PMID: 10383159.
Sampath et al (2006) Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial. Blood. 107 2517. PMID: 16293603.
If you know of a relevant citation for this product please let us know.
Keywords: Cytarabine, supplier, Cytarabine, supplier, ara-C, araC, cytosine, beta-D-arabinofuranoside, arabinocytidine, DNA, replication, inhibits, nucleoside, analog, deoxycytidine, incorporates, synthesis, anticancer, antiproliferative, antineoplastic, antileukemic, leukemia, fragmentation
Find multiple products by catalog number
New Products in this Area
Irreversible mitochondrial respiratory complex II inhibitorCapecitabine
Prodrug of 5-Fluorouracil (Cat. No. 3257). Inhibits DNA synthesis8-Chloroadenosine
Cytotoxic nucleoside analog; inhibits RNA synthesis
Win a Kindle
June 3 - 5, 2013
Booth Number: C54